Ajovy Injection

Description

Ajovy® (fremanezumab-vfrm) Injection – 225 mg/1.5 mL Prefilled Syringe

Product Description: Ajovy® is a prescription medicine used for the preventive treatment of migraine in adults. It contains fremanezumab-vfrm, a humanized monoclonal antibody that targets the calcitonin gene-related peptide (CGRP), a protein involved in migraine attacks. Ajovy is designed to help reduce the frequency of migraine days in individuals suffering from episodic or chronic migraine.

Product Features:

• Active Ingredient: Fremanezumab-vfrm

• Strength: 225 mg per 1.5 mL

• Dosage Form: Subcutaneous injection

• Presentation: Single-dose prefilled syringe

• Administration: Once monthly (225 mg) or quarterly (675 mg as 3 consecutive injections)

• Route of Administration: Subcutaneous (under the skin)